ArticleThe Journal of clinical investigation2026

Loss of Kmt2c/d promotes gastric cancer and confers vulnerability to mTORC1 and PD-1 inhibition.

Naitao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.